Literature DB >> 34966624

Infective Aortic Valve Endocarditis in a Patient With Mixed Connective Tissue Disease.

Leonor Boavida1, Joana Azevedo Carvalho1, Frederico Batista2, Susana Oliveira1, José Alves1.   

Abstract

Mixed connective tissue disease (MCTD) is a rare autoimmune disorder that is characterized by overlapping clinical features of systemic lupus erythematosus (SLE), scleroderma, and myositis. Both SLE and mixed connective tissue disease patients are more prone to have acute endocarditis, and immunosuppression is a risk factor for recurrence of infective endocarditis. We present the case of a 53-year-old female with mixed connective tissue disease presenting with interstitial lung disease and precapillary pulmonary hypertension. The patient was chronically medicated with prednisolone, mycophenolate mofetil, and hydroxychloroquine. She was admitted for Enterococcus faecalis infective endocarditis and was treated with a four-week course of ceftriaxone and ampicillin. Immunosuppressive chronic medication was maintained due to severe lung involvement. One month later, the patient was re-admitted due to respiratory infection with identification of influenza B virus. However, fever persisted for over one week, and subsequent relapse of the E. faecalis infective endocarditis was found. The diagnosis was made based on blood cultures and a transoesophageal echocardiogram. No other focus of infection was identified. She completed a six-week course of vancomycin and gentamicin and underwent cardiac surgery with success. This case highlights the difficulty of the management of immunosuppressed patients in the presence of serious infections.
Copyright © 2021, Boavida et al.

Entities:  

Keywords:  autoimmunity; enterococcus faecalis; immunosuppression; infective endocarditis relapse; mixed connective tissue disease

Year:  2021        PMID: 34966624      PMCID: PMC8710065          DOI: 10.7759/cureus.20681

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  12 in total

1.  Effect of antibiotic treatment on vegetation size and complication rate in infective endocarditis.

Authors:  S Rohmann; R Erhel; H Darius; T Makowski; J Meyer
Journal:  Clin Cardiol       Date:  1997-02       Impact factor: 2.882

2.  Repeat infective endocarditis: differentiating relapse from reinfection.

Authors:  Vivian H Chu; Daniel J Sexton; Christopher H Cabell; L Barth Reller; Paul A Pappas; Rakesh K Singh; Vance G Fowler; G Ralph Corey; Olcay Aksoy; Christopher W Woods
Journal:  Clin Infect Dis       Date:  2005-06-14       Impact factor: 9.079

3.  Mixed connective tissue disease--an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA).

Authors:  G C Sharp; W S Irvin; E M Tan; R G Gould; H R Holman
Journal:  Am J Med       Date:  1972-02       Impact factor: 4.965

4.  Prevalence of infective endocarditis in patients with systemic lupus erythematosus.

Authors:  C S Miller; R M Egan; D A Falace; M K Rayens; C R Moore
Journal:  J Am Dent Assoc       Date:  1999-03       Impact factor: 3.634

Review 5.  Guidelines for the diagnosis and antibiotic treatment of endocarditis in adults: a report of the Working Party of the British Society for Antimicrobial Chemotherapy.

Authors:  F Kate Gould; David W Denning; Tom S J Elliott; Juliet Foweraker; John D Perry; Bernard D Prendergast; Jonathan A T Sandoe; Michael J Spry; Richard W Watkin
Journal:  J Antimicrob Chemother       Date:  2011-11-14       Impact factor: 5.790

6.  Increased risk for heart valve disease associated with antiphospholipid antibodies in patients with systemic lupus erythematosus: meta-analysis of echocardiographic studies.

Authors:  S Zuily; V Regnault; C Selton-Suty; V Eschwège; J-F Bruntz; E Bode-Dotto; E De Maistre; P Dotto; C Perret-Guillaume; T Lecompte; D Wahl
Journal:  Circulation       Date:  2011-06-20       Impact factor: 29.690

7.  Recurrent infective endocarditis.

Authors:  I S Lossos; R Oren
Journal:  Postgrad Med J       Date:  1993-10       Impact factor: 2.401

Review 8.  Revisiting Libman-Sacks endocarditis: a historical review and update.

Authors:  Jennifer L Lee; Stanley M Naguwa; Gurtej S Cheema; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2009-06       Impact factor: 8.667

9.  Transthoracic versus transesophageal echocardiography for detection of Libman-Sacks endocarditis: a randomized controlled study.

Authors:  Carlos A Roldan; Clifford R Qualls; Karen S Sopko; Wilmer L Sibbitt
Journal:  J Rheumatol       Date:  2007-12-15       Impact factor: 4.666

10.  Aortic valve replacement for Libman-Sacks endocarditis.

Authors:  Jack B Keenan; Taufiek Konrad Rajab; Rajesh Janardhanan; Brandon T Larsen; Zain Khalpey
Journal:  BMJ Case Rep       Date:  2016-10-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.